NYSE:CLB Core Laboratories (CLB) Stock Price, News & Analysis $17.69 -0.35 (-1.94%) (As of 09/6/2024 ET) Add Compare Share Share Today's Range$17.35▼$18.1750-Day Range$17.68▼$24.5352-Week Range$13.82▼$26.49Volume270,526 shsAverage Volume452,264 shsMarket Capitalization$829.66 millionP/E Ratio20.10Dividend Yield0.23%Price Target$18.50 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends Get Core Laboratories alerts: Email Address Core Laboratories MarketRank™ Stock AnalysisAnalyst RatingReduce1.50 Rating ScoreUpside/Downside4.6% Upside$18.50 Price TargetShort InterestBearish17.06% of Float Sold ShortDividend StrengthWeakBased on Four FactorsSustainabilityN/ANews SentimentN/AInsider TradingN/AProj. Earnings Growth46.84%From $0.79 to $1.16 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.0.54 out of 5 starsOils/Energy Sector231st out of 239 stocksOil & Gas Field Services, Not Elsewhere Classified Industry15th out of 17 stocks 0.8 Analyst's Opinion Consensus RatingCore Laboratories has received a consensus rating of Reduce. The company's average rating score is 1.50, and is based on no buy ratings, 2 hold ratings, and 2 sell ratings.Amount of Analyst CoverageCore Laboratories has only been the subject of 3 research reports in the past 90 days.Read more about Core Laboratories' stock forecast and price target. Previous Next 1.0 Short Interest Percentage of Shares Shorted17.06% of the float of Core Laboratories has been sold short.Short Interest Ratio / Days to CoverCore Laboratories has a short interest ratio ("days to cover") of 16.5, which indicates bearish sentiment.Change versus previous monthShort interest in Core Laboratories has recently decreased by 3.29%, indicating that investor sentiment is improving. Previous Next 1.7 Dividend Strength Dividend YieldCore Laboratories has a dividend yield of 0.22%, which is in the bottom 25% of all stocks that pay dividends.Dividend GrowthCore Laboratories does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Core Laboratories is 4.55%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, Core Laboratories will have a dividend payout ratio of 3.45% next year. This indicates that Core Laboratories will be able to sustain or increase its dividend.Read more about Core Laboratories' dividend. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for CLB. Previous Next 1.2 News and Social Media Coverage News SentimentCore Laboratories has a news sentiment score of 0.20. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.64 average news sentiment score of Oils/Energy companies.News Coverage This WeekMarketBeat has tracked 1 news article for Core Laboratories this week, compared to 3 articles on an average week.Search InterestOnly 1 people have searched for CLB on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.MarketBeat FollowsOnly 1 people have added Core Laboratories to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Core Laboratories insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 0.76% of the stock of Core Laboratories is held by insiders.Percentage Held by Institutions97.81% of the stock of Core Laboratories is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Core Laboratories' insider trading history. Previous Next 2.5 Earnings and Valuation Earnings GrowthEarnings for Core Laboratories are expected to grow by 46.84% in the coming year, from $0.79 to $1.16 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Core Laboratories is 20.10, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 127.80.Price to Earnings Ratio vs. SectorThe P/E ratio of Core Laboratories is 20.10, which means that it is trading at a more expensive P/E ratio than the Oils/Energy sector average P/E ratio of about 13.78.Price to Earnings Growth RatioCore Laboratories has a PEG Ratio of 1.14. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioCore Laboratories has a P/B Ratio of 3.38. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Core Laboratories' valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Porter & CompanyThe death of Nvidia?Today, I’m warning of another looming catastrophe. Only this time, it’s not in pot stocks, cryptos, or U.S. housing… it's in artificial intelligence. And unless you know what’s really going on in this sector, you could be wiped out. You see, while there is no doubt that the recent advancements in artificial intelligence are game-changing and will drive colossal innovation in every sector of the economy... There's also no escaping that The Big AI Die-Up is coming.So go here now to read my new report The Big AI Die-Up… while you still can. About Core Laboratories Stock (NYSE:CLB)Core Laboratories Inc. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and oil delivered products; and proprietary and joint industry studies, as well as services that support carbon capture, utilization and storage, geothermal projects, and the evaluation and appraisal of mining activities. The Production Enhancement segment provides services and products relating to reservoir well completions, perforations, stimulations, production, and well abandonment. It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. The company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. Core Laboratories Inc. was founded in 1936 and is based in Houston, Texas.Read More CLB Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CLB Stock News HeadlinesAugust 23, 2024 | uk.finance.yahoo.comCore Laboratories (CLB) Down 25.6% Since Last Earnings Report: Can It Rebound?August 22, 2024 | msn.comCore Laboratories (CLB) Rose After Earnings BeatSeptember 7, 2024 | Paradigm Press (Ad) Fmr CIA Advisor reveals PEACEMAKER superweaponKamala cannot get the “codes” to this superweapon. In Trump’s hands, it will restore America’s global dominance. It could also help Americans struggling under Bidenomics by potentially sending 5 military stocks SOARING. Historically, similar stocks have shot up 16,270% in just 18 months.August 14, 2024 | nz.finance.yahoo.comCore Laboratories Inc. (HJ1.F)July 28, 2024 | finance.yahoo.comCore Laboratories Second Quarter 2024 Earnings: Misses ExpectationsJuly 24, 2024 | prnewswire.comCORE LAB REPORTS SECOND QUARTER 2024 RESULTSJuly 24, 2024 | gurufocus.comCore Laboratories Inc (CLB) Q2 2024 Earnings: Revenue at $130.6M, GAAP EPS at $0. ...July 23, 2024 | markets.businessinsider.comHere's what Wall Street expects from Core Laboratories's earnings reportSeptember 7, 2024 | Paradigm Press (Ad) Fmr CIA Advisor reveals PEACEMAKER superweaponKamala cannot get the “codes” to this superweapon. In Trump’s hands, it will restore America’s global dominance. It could also help Americans struggling under Bidenomics by potentially sending 5 military stocks SOARING. Historically, similar stocks have shot up 16,270% in just 18 months.July 19, 2024 | msn.comECB eyes summer pause on bumpy road to disinflationMay 28, 2024 | msn.comGerman, Baltic call for better digital infrastructure, data sharingMay 23, 2024 | finance.yahoo.comIs There An Opportunity With Core Laboratories Inc.'s (NYSE:CLB) 26% Undervaluation?May 22, 2024 | finance.yahoo.comCore Laboratories Inc. (CLB)May 2, 2024 | finance.yahoo.comCore Laboratories Inc.'s (NYSE:CLB) CEO Compensation Is Looking A Bit Stretched At The MomentApril 30, 2024 | finance.yahoo.comCore Laboratories N.V. (NYSE:CLB) Q1 2024 Earnings Call TranscriptApril 29, 2024 | finance.yahoo.comThese Return Metrics Don't Make Core Laboratories (NYSE:CLB) Look Too StrongApril 27, 2024 | seekingalpha.comCore Laboratories Inc. (CLB) Q1 2024 Earnings Call TranscriptApril 26, 2024 | finance.yahoo.comQ1 2024 Core Laboratories Inc Earnings CallSee More Headlines Receive CLB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Core Laboratories and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings7/24/2024Ex-Dividend for 8/26 Dividend8/05/2024Dividend Payable8/26/2024Today9/07/2024Next Earnings (Estimated)11/06/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorOils/Energy Industry Oil & gas field services, not elsewhere classified Sub-IndustryPetroleum And Natural Gas Current SymbolNYSE:CLB CUSIPN/A CIK1000229 Webwww.corelab.com Phone(713) 328-2673FaxN/AEmployees3,600Year Founded1936Price Target and Rating Average Stock Price Target$18.50 High Stock Price Target$22.00 Low Stock Price Target$15.00 Potential Upside/Downside+4.6%Consensus RatingReduce Rating Score (0-4)1.50 Research Coverage4 Analysts Profitability EPS (Most Recent Fiscal Year)$0.88 Trailing P/E Ratio20.10 Forward P/E Ratio22.39 P/E Growth1.14Net Income$36.67 million Net Margins5.44% Pretax Margin7.87% Return on Equity15.20% Return on Assets6.06% Debt Debt-to-Equity Ratio0.60 Current Ratio2.39 Quick Ratio1.68 Sales & Book Value Annual Sales$513.77 million Price / Sales1.61 Cash Flow$0.96 per share Price / Cash Flow18.43 Book Value$5.24 per share Price / Book3.38Miscellaneous Outstanding Shares46,900,000Free Float46,544,000Market Cap$829.66 million OptionableOptionable Beta2.41 Social Links Beginners Guide To Retirement StocksClick the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report Key ExecutivesMr. Lawrence V. Bruno (Age 63)Chairman of the Board, CEO, President & COO Comp: $1.47MMr. Christopher Scott Hill (Age 54)Senior VP & CFO Comp: $668.8kMs. Gwendolyn Y. Gresham M.B.A. (Age 56)Senior Vice President of Corporate Development & Investor Relations Comp: $574.19kMr. Mark Damian Tattoli (Age 52)Senior VP, Secretary & General Counsel Comp: $565.11kMr. Sow Hang Teo (Age 54)VP, Treasurer & Chief Accounting Officer Mr. Jacobus Schouten (Age 69)Managing Director Comp: $26.35kJ. Donald Dumas Jr.Senior VP of Production Enhancement & Business DevelopmentMore ExecutivesKey CompetitorsCalifornia ResourcesNYSE:CRCLiberty EnergyNYSE:LBRTBlack Stone MineralsNYSE:BSMTalos EnergyNYSE:TALOExpro GroupNYSE:XPROView All CompetitorsInstitutional OwnershipTruist Financial CorpSold 5,158 shares on 8/21/2024Ownership: 0.028%Disciplined Growth Investors Inc. MNBought 3,644,963 shares on 8/16/2024Ownership: 9.511%Creative PlanningBought 15,196 shares on 8/16/2024Ownership: 0.117%Northwestern Mutual Wealth Management Co.Bought 600 shares on 8/16/2024Ownership: 0.012%The Manufacturers Life Insurance Company Bought 579 shares on 8/15/2024Ownership: 0.038%View All Institutional Transactions CLB Stock Analysis - Frequently Asked Questions How have CLB shares performed this year? Core Laboratories' stock was trading at $17.66 at the beginning of the year. Since then, CLB stock has increased by 0.2% and is now trading at $17.69. View the best growth stocks for 2024 here. How were Core Laboratories' earnings last quarter? Core Laboratories Inc. (NYSE:CLB) announced its quarterly earnings data on Wednesday, July, 24th. The oil and gas company reported $0.22 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.21 by $0.01. Core Laboratories's revenue for the quarter was up 2.1% on a year-over-year basis. What is David M. Demshur's approval rating as Core Laboratories' CEO? 60 employees have rated Core Laboratories Chief Executive Officer David M. Demshur on Glassdoor.com. David M. Demshur has an approval rating of 36% among the company's employees. This puts David M. Demshur in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies. Who are Core Laboratories' major shareholders? Core Laboratories' top institutional investors include Ariel Investments LLC (21.95%), Disciplined Growth Investors Inc. MN (9.51%), Earnest Partners LLC (7.01%) and Dimensional Fund Advisors LP (1.60%). View institutional ownership trends. How do I buy shares of Core Laboratories? Shares of CLB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Core Laboratories own? Based on aggregate information from My MarketBeat watchlists, some other companies that Core Laboratories investors own include Xtrackers California Municipal Bond ETF (CA), BlackRock (BLK), Starbucks (SBUX), Micron Technology (MU), Chipotle Mexican Grill (CMG), Endologix (ELGX) and Intel (INTC). This page (NYSE:CLB) was last updated on 9/7/2024 by MarketBeat.com Staff From Our PartnersPerfect Crypto Buying Opportunity for 50 CentsWhen cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying wit...Crypto 101 Media | SponsoredThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." ...Sasco Gold LLC | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredThese 5 stocks could soar after November 4thHow to Trade this Crazy Election Year? Simple – Just Focus on These 5 stocks… Now available – a free report...StockEarnings | SponsoredMan who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Core Laboratories Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Core Laboratories With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.